RECRUITING

Neurofeedback During Eating for Bulimia Nervosa

Conditions

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The purpose of this study is to examine the effects of noninvasive prefrontal cortex (PFC) neurofeedback during eating in women with bulimia nervosa (BN) using a wearable brain imaging device, functional near-infrared spectroscopy (fNIRS). The investigators will examine how this training may influence inhibitory control and BN symptoms.

Official Title

Neurofeedback During Eating: A Novel Mechanistic Treatment for Bulimia Nervosa

Quick Facts

Study Start:2024-05-13
Study Completion:2024-12
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT05614024

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years to 45 Years
Sexes Eligible for Study:FEMALE
Accepts Healthy Volunteers:No
Standard Ages:ADULT
Inclusion CriteriaExclusion Criteria
  1. * Female
  2. * Aged 18 to 45 years
  3. * Meet diagnostic criteria for bulimia nervosa
  4. * Current body mass index greater than or equal to 18.5kg/m2 but under 30kg/m2
  5. * English-speaking
  1. * Ongoing medical treatment, major medical condition, or psychiatric disorder that may interfere with study variables or participation
  2. * Current psychotherapy focused primarily on eating disorder symptoms
  3. * Pregnancy or planned pregnancy, or lactation during the study period
  4. * Allergy to ingredients in the standardized meal or in the shake

Contacts and Locations

Study Contact

Jessica Qiu, B.A.
CONTACT
212-201-2679
jessica.qiu@mssm.edu
Laura A Berner, Ph.D.
CONTACT
laura.berner@mssm.edu

Principal Investigator

Laura A Berner, Ph.D.
PRINCIPAL_INVESTIGATOR
Icahn School of Medicine at Mount Sinai

Study Locations (Sites)

Center for Computational Psychiatry at the Icahn School of Medicine at Mount Sinai
New York, New York, 10027
United States

Collaborators and Investigators

Sponsor: Icahn School of Medicine at Mount Sinai

  • Laura A Berner, Ph.D., PRINCIPAL_INVESTIGATOR, Icahn School of Medicine at Mount Sinai

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2024-05-13
Study Completion Date2024-12

Study Record Updates

Study Start Date2024-05-13
Study Completion Date2024-12

Terms related to this study

Additional Relevant MeSH Terms

  • Bulimia Nervosa